Myelodysplastic syndrome in a patient with Barth syndrome (3-methylglutaconic aciduria type II)
Pediatr Blood Cancer
.
2023 Mar;70(3):e30033.
doi: 10.1002/pbc.30033.
Epub 2022 Oct 2.
Authors
Shin-Ichi Tsujimoto
1
2
,
Kenichi Sakamoto
1
3
,
Yoshiko Nakano
4
,
Takanori Mizuno
1
5
,
Takahiro Shindo
6
,
Junichi Watanabe
7
,
Aiko Sato-Otsubo
5
,
Tomoo Osumi
1
,
Kimikazu Matsumoto
1
,
Daisuke Tomizawa
1
,
Motohiro Kato
1
4
5
Affiliations
1
Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
2
Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
3
Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.
4
Department of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan.
5
Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
6
Division of Cardiology, National Center for Child Health and Development, Tokyo, Japan.
7
Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
PMID:
36184828
DOI:
10.1002/pbc.30033
No abstract available
Publication types
Letter
MeSH terms
Barth Syndrome*
Humans
Metabolism, Inborn Errors*
Mutation
Myelodysplastic Syndromes* / complications
Supplementary concepts
3-Methylglutaconic Aciduria